Varun Govil
Amministratore Delegato presso Epinoma, Inc.
Profilo
Varun Govil is currently working as a Venture Partner at Pioneer Fund and as Secretary, Chief Executive & Financial Officer at Epinoma, Inc. He completed his undergraduate degree from the University of California San Diego in 2020.
Posizioni attive di Varun Govil
| Società | Posizione | Inizio |
|---|---|---|
Epinoma, Inc.
 Epinoma, Inc. BiotechnologyHealth Technology Epinoma, Inc. is an early-stage biotechnology company based in San Carlos, CA. The company is developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. The company has received early backing from renowned Harvard geneticist Dr. George Church and has established a strong research collaboration with researchers at TU Dortmund. Epinoma plans to onboard early access liquid biopsy and biopharma customers in late 2022. The CEO of the company is Varun Govil. | Amministratore Delegato | - |
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Investitore di Private Equity | - |
Formazione di Varun Govil
| University of California San Diego | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Epinoma, Inc.
Epinoma, Inc. BiotechnologyHealth Technology Epinoma, Inc. is an early-stage biotechnology company based in San Carlos, CA. The company is developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. The company has received early backing from renowned Harvard geneticist Dr. George Church and has established a strong research collaboration with researchers at TU Dortmund. Epinoma plans to onboard early access liquid biopsy and biopharma customers in late 2022. The CEO of the company is Varun Govil. | Health Technology |
- Borsa valori
- Insiders
- Varun Govil
